(Q46891656)

26 December 2017

title

Population pharmacokinetics and pharmacodynamics of peptidic erythropoiesis receptor agonist (ERA) in healthy volunteers (English)

1 reference

26 December 2017

1 reference

1 reference

5

William J Jusko

1 reference

26 December 2017

author name string

Sukyung Woo

1

1 reference

26 December 2017

Wojciech Krzyzanski

2

1 reference

26 December 2017

Anne-Marie Duliege

3

1 reference

26 December 2017

Richard B Stead

4

1 reference

26 December 2017

publication date

19 November 2007

1 reference

26 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

26 December 2017

volume

48

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

43-52

1 reference

26 December 2017

Development and characterization of novel erythropoiesis stimulating protein (NESP)

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309702

Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309702

Development and characterization of novel erythropoiesis stimulating protein (NESP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309702

Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309702

Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309702

Small peptides as potent mimetics of the protein hormone erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309702

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309702

Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309702

Population cell life span models for effects of drugs following indirect mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309702

Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309702

Is it time for a paradigm shift? Is erythropoietin deficiency still the main cause of renal anaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309702

Pharmacokinetic analysis of subcutaneous erythropoietin administration with nonlinear mixed effect model including endogenous production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309702

Predicting the time course of haemoglobin in children treated with erythropoietin for renal anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309702

21 January 2018

Identifiers

DOI

10.1177/0091270007309702

1 reference

26 December 2017

1 reference

26 December 2017